As previously stated, the Q2 will have long term care and remote monitoring revenue. That, and RXMD is aggressively growing their 340B revenue. There had also been ClearMetrX growth in the recent past, though I don't know if that will have grown in Q2. It's not all doom and gloom, just the PPS.